Showing results (21-30 of 32) with videos related to
Sort By:
Pageof 4
ACS Central Science|December 7, 2019
Site-Selective C-H Halogenation Using Flavin-Dependent Halogenases Identified via Family-Wide Activity ProfilingBrian F Fisher, Harrison M Snodgrass, Krysten A Jones, et al.Plos One|May 15, 2013
Tgf-β1 inhibits Cftr biogenesis and prevents functional rescue of ΔF508-Cftr in primary differentiated human bronchial epithelial cellsSteven M Snodgrass, Kristine M Cihil, Pamela K Cornuet, et al.The American Journal of Clinical Nutrition|April 1, 1982
Lightly hydrogenated soy oil versus other vegetable oils as a lipid-lowering dietary constituentD C Laine, C M Snodgrass, E A Dawson, et al.Journal of Neuro-Oncology|March 1, 1996
Delayed, transient encephalopathy after marrow transplantation: case reports and MRI findings in four patientsH I Tahsildar, B F Remler, R J Creger, et al.American Journal of Clinical Oncology|June 1, 1994
The role of steroids in the management of metastatic carcinoma to the brain. A pilot prospective trialA H Wolfson, S M Snodgrass, J G Schwade, et al.Angewandte Chemie (International Ed. in English)|October 25, 2022
The Single-Component Flavin Reductase/Flavin-Dependent Halogenase AetF is a Versatile Catalyst for Selective Bromination and Iodination of Arenes and OlefinsYuhua Jiang, Harrison M Snodgrass, Yasmine S Zubi, et al.Tobacco Control|October 28, 2015
Tobacco smoke exposure and respiratory morbidity in young childrenA M Snodgrass, P T Tan, S E Soh, et al.ACS Chemical Biology|March 30, 2026
Investigating Opioid Receptor Activity through Biocatalytic Halogenation and Oxidation of MitragynineNatalia R Harris, Alexander J Powell, Harrison M Snodgrass, et al.Biorxiv : the Preprint Server for Biology|February 20, 2025
Advancing (-)-Premarineosin A as a Potent Antimalarial Therapeutic via Metabolic Engineering and Late-Stage DerivatizationChristina M McBride, Morgan McCauley, Natalia R Harris, et al.Journal of Neuro-Oncology|October 11, 2011
Phase I study of panobinostat in combination with bevacizumab for recurrent high-grade gliomaJ Drappatz, E Q Lee, S Hammond, et al.Pageof 4